Please login to the form below

Not currently logged in


This page shows the latest Allegro news and features for those working in and with pharma, biotech and healthcare.

Ashfield welcomes second intake of medical writers

Ashfield welcomes second intake of medical writers

Ashfield Healthcare Communications, a global healthcare communications agency part of the UDG Healthcare group, has welcomed its second intake of aspiring medical writers into its fast-track training programme Allegro. ... Ashfield aims to train up to 80

Latest news

  • Multiplying options for MS

    Gilenya. In December 2010, top-line results from the pivotal phase III ALLEGRO trial were announced, indicating that the drug met its primary endpoint of reducing annualised relapse rates in patients ... Completion of this trial is expected later in 2011.

  • MS treatment hopes

    or placebo, and the similar, two-armed (laquinimod versus placebo) ALLEGRO trial.

  • Teva begins second Phase III trial of oral MS treatment

    The BRAVO trial will run alongside the ongoing ALLEGRO trial, a similar global, double-blind study involving around 1, 000 patients.

  • Health warning

    It is an Austin Allegro system in a Ferrari world. It is fish paste sandwiches in a Pret A Manger world.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...